Anti-inflammatory and intestinal barrier-protective activities of commensal lactobacilli and bifidobacteria in thoroughbreds: Role of probiotics in diarrhea prevention in neonatal Thoroughbreds

Journal of Equine Science

Volumn 25, Issue 2, 2014, Pages 37-43

  Tanabe, Soichi ^a   Suzuki, Takuya ^a   Wasano, Yuichiro ^a   Nakajima, Fumihiko ^b   Kawasaki, Hiroshi ^b   Tsuda, Tomonori ^b   Nagamine, Natsuko ^b   Tsurumachi, Takashi ^b   Sugaya, Kiyoshi ^b   Akita, Hiroaki ^b   Takagi, Misako ^c   Takagi, Kunihiko ^d   Inoue, Yoshinobu ^e   Asai, Yo ^e   Morita, Hidetoshi ^d  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Northern Farm   (Japan)

^c Crossfeld Bio Inc   (Japan)

^d AZABU UNIVERSITY   (Japan)

^e EQUINE RESEARCH INSTITUTE   (Japan)

Author keywords

Diarrhea prevention; Interleukin 17; Probiotics; Thoroughbred

Indexed keywords

EID: 84903271313     PISSN: 13403516     EISSN: 13477501     Source Type: Journal    
DOI: 10.1294/jes.25.37     Document Type: Article

References (26)

1. Allen, S.J., Wareham, K., Wang, D., Bradley, C., Hutch-ings, H., Harris, W., Dhar, A., Brown, H., Foden, A., Gravenor, M.B., and Mack, D. 2013. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium diffcile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 382: 1249-1257. [Medline] [CrossRef]
2. Al-Sadi, R., Guo, S., Ye, D., and Ma, T.Y. 2013. TNF-α modulation of intestinal epithelial tight junction barrier is regulated by ERK1/2 activation of Elk-1. Am. J. Pathol. 183: 1871-1884. [Medline] [CrossRef]
3. Cario, E., Gerken, G., and Podolsky, D.K. 2007. Toll-like receptor 2 controls mucosal infammation by regulating epithelial barrier function. Gastroenterology 132: 1359-1374. [Medline] [CrossRef]
4. Endo, A., Okada, S., and Morita, H. 2007. Molecular profling of Lactobacillus, Streptococcus, and Bifdobac-terium species in feces of active racehorses. J. Gen. Appl. Microbiol. 53: 191-200. [Medline] [CrossRef]
5. Fukuda, S., Toh, H., Hase, K., Oshima, K., Nakanishi, Y., Yoshimura, K., Tobe, T., Clarke, J.M., Topping, D.L., Suzuki, T., Taylor, T.D., Itoh, K., Kikuchi, J., Morita, H., Hattori, M., and Ohno, H. 2011. Bifdobacteria can protect from enteropathogenic infection through production of acetate. Nature 469: 543-547. [Medline] [CrossRef]
6. Hempel, S., Newberry, S.J., Maher, A.R., Wang, Z., Miles, J.N.V., Shanman, R., Johnsen, B., and Shekelle, P.G. 2012. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 307: 1959-1969. [Medline] [CrossRef]
7. Hickson, M., D'Souza, A.L., Muthu, N., Rogers, T.R., Want, S., Rajkumar, C., and Bulpitt, C.J. 2007. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 335: 80. [Medline] [CrossRef]
8. Koelink, P.J., Overbeek, S.A., Braber, S., de Kruijf, P., Folkerts, G., Smit, M.J., and Kraneveld, A.D. 2012. Targeting chemokine receptors in chronic infammatory diseases: an extensive review. Pharmacol. Ther. 133: 1-18. [Medline] [CrossRef]
9. Mitsuoka, T., and Kaneuchi, C. 1977. Ecology of the bif-dobacteria. Am. J. Clin. Nutr. 30: 1799-1810. [Medline]
10. Miyauchi, E., Morita, H., Okuda, J., Sashihara, T., Shimizu, M., and Tanabe, S. 2008. Cell wall fraction of Enterococcus hirae ameliorates TNF-alpha-induced barrier impairment in the human epithelial tight junction. Lett. Appl. Microbiol. 46: 469-476. [Medline] [CrossRef]
11. Miyauchi, E., Morita, H., and Tanabe, S. 2009. Lactoba-cillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo. J. Dairy Sci. 92: 2400-2408. [Medline] [CrossRef]
12. Morita, H., Nakajima, F., Murakami, M., Endo, A., Suzuki, T., Shiratori, C., Kato, Y., Okatani, T.A., Akita, H., and Masaoka, T. 2007. Molecular monitoring of the main changes in bacterial foral diversity in the gastrointestinal tract of a thoroughbred foal with catarrhal enteritis by using PCR-DGGE. J. Equine Vet. Sci. 27: 14-19. [CrossRef]
13. Morita, H., Nakano, A., Shimazu, M., Toh, H., Nakajima, F., Nagayama, M., Hisamatsu, S., Kato, Y., Takagi, M., Takami, H., Akita, H., Matsumoto, M., Masaoka, T., and Murakami, M. 2009. Lactobacillus hayakitensis, L. equigenerosi and L. equi, predominant lactobacilli in the intestinal fora of healthy thoroughbreds. Anim. Sci. J. 80: 339-346. [Medline] [CrossRef]
14. Morita, H., Shimazu, M., Shiono, H., Toh, H., Nakajima, F., Akita, H., Takagi, M., Takami, H., Murakami, M., Masaoka, T., Tanabe, S., and Hattori, M. 2010. Lactoba-cillus equicursoris sp. nov., isolated from the faeces of a thoroughbred racehorse. Int. J. Syst. Evol. Microbiol. 60: 109-112. [Medline] [CrossRef]
15. Morotomi, M., Yuki, N., Kado, Y., Kushiro, A., Shimazaki, T., Watanabe, K., and Yuyama, T. 2002. Lactobacillus equi sp. nov., a predominant intestinal Lactobacillus species of the horse isolated from faeces of healthy horses. Int. J. Syst. Evol. Microbiol. 52: 211-214. [Medline]
16. Muyzer, G., and Smalla, K. 1998. Application of denaturing gradient gel electrophoresis (DGGE) and temperature gradient gel electrophoresis (TGGE) in microbial ecology. Antonie van Leeuwenhoek 73: 127-141. [Medline] [CrossRef]
17. Ngendahayo Mukiza, C., and Dubreuil, J.D. 2013. Esch-erichia coli heat-stable toxin b impairs intestinal epithelial barrier function by altering tight junction proteins. Infect. Immun. 81: 2819-2827. [Medline] [CrossRef]
18. Ogita, T., Nakashima, M., Morita, H., Saito, Y., Suzuki, T., and Tanabe, S. 2011. Streptococcus thermophilus ST28 ameliorates colitis in mice partially by suppression of infammatory Th17 cells. J. Biomed. Biotechnol. 2011: 378417. [Medline] [CrossRef]
19. Ohland, C.L., and Macnaughton, W.K. 2010. Probiotic bacteria and intestinal epithelial barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 298: G807-G819. [Medline] [CrossRef]
20. Rachmilewitz, D., Katakura, K., Karmeli, F., Hayashi, T., Reinus, C., Rudensky, B., Akira, S., Takeda, K., Lee, J., Takabayashi, K., and Raz, E. 2004. Toll-like receptor 9 signaling mediates the anti-infammatory effects of pro-biotics in murine experimental colitis. Gastroenterology 126: 520-528. [Medline] [CrossRef]
21. Suenaert, P., Bulteel, V., Lemmens, L., Noman, M., Geypens, B., Van Assche, G., Geboes, K., Ceuppens, J.L., and Rutgeerts, P. 2002. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. Am. J. Gastroenterol. 97: 2000-2004. [Medline] [CrossRef]
22. Tanabe, S. 2013. The effect of probiotics and gut mi-crobiota on Th17 cells. Int. Rev. Immunol. 32: 511-525. [Medline] [CrossRef]
23. Tanabe, S., Kinuta, Y., and Saito, Y. 2008. Bifdobacte-rium infantis suppresses proinfammatory interleukin-17 production in murine splenocytes and dextran sodium sulfate-induced intestinal infammation. Int. J. Mol. Med. 22: 181-185. [Medline]
24. Ogita, T., Tanii, Y., Morita, H., Suzuki, T., and Tanabe, S. 2011. Suppression of Th17 response by Streptococcus thermophilus ST28 through induction of IFN-γ. Int. J. Mol. Med. 28: 817-822. [Medline]
25. Walter, J., Hertel, C., Tannock, G.W., Lis, C.M., Munro, K., and Hammes, W.P. 2001. Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specifc PCR primers and denaturing gradient gel electrophoresis. Appl. Environ. Microbiol. 67: 2578-2585. [Medline] [CrossRef]
26. Wong, S., Jamous, A., O'Driscoll, J., Sekhar, R., Weldon, M., Yau, C.Y., Hirani, S.P., Grimble, G., and Forbes, A. 2014. A Lactobacillus casei Shirota probiotic drink reduces antibiotic-associated diarrhoea in patients with spinal cord injuries: a randomised controlled trial. Br. J. Nutr. 111: 672-678. [Medline] [CrossRef]